Beware of Sprott bearing loans, perhaps. But as you said, this doc is Sprott's perspective of the deal.
Somehow I doubt that EMR directors perceive it as Sprott having a boot on their throat. With financing in the bag, it opens the door EMR to go sniffing elsewhere for the additional cash,or alternatively,a possible merger with CMM, for example.
Looks like EMR has a few trees to go and shake and see what falls out. Let's see what transpires.
A.I.
Sprott Equity Research EMR., page-11
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.16 |
Change
-0.060(1.42%) |
Mkt cap ! $2.732B | |||
| Open | High | Low | Value | Volume |
| $4.15 | $4.21 | $4.11 | $4.109M | 986.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1978 | $4.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.19 | 3447 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| EMR (ASX) Chart |